Anzeige
Mehr »
Login
Donnerstag, 25.04.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Wie die Revolution der sauberen Energie eine solide Investitionsmöglichkeit bieten könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
1.775 Leser
Artikel bewerten:
(2)

KinetiCor Names Twenty-One Year Veteran of GE and GE Healthcare, Michael Jones, as Chairman of its Business Advisory Board

Leading Provider of Prospective Motion Detection and Correction Technology for MRI Charts Strategy to Meet Global Demand

SAN DIEGO, Feb. 17, 2020 (GLOBE NEWSWIRE) -- KinetiCor, Inc., today's only FDA 510(k) cleared optical motion detection solution1 for advanced Magnetic Resonance Imaging (MRI) scanners, is pleased to announce the appointment of Michael A. Jones as Chairman of its Board of Advisors. With over twenty-one years in corporate development, strategy, and M&A experience during his career at General Electric, Mike is chartered to help guide KinetiCor's strategic expansion across the global MRI market.

"We look forward to Michael's guidance and insight as we expand our technical focus and reach to new markets," said Doug Donzelli, CEO of KinetiCor. "The KinetiCor technology is highly-differentiated and offers the potential for powerful improvements to MRI results. Michael's experience at GE, broad industry relationships, and global perspective will help us bring this important advancement in MRI diagnostics to a greater number of patients around the world."

A pioneer in prospective motion detection and correction, the KinetiCor platform offers the potential to improve the MRI experience for patients and technicians, as well as improve the efficiency of MRI operations due to undetected movement. With KinetiCor, physicians can have access to more accurate, high-definition MRI scans the first time, giving them the potential to make more accurate diagnoses and create better patient outcomes. The KinetiCor platform is available today, embedded within Siemens Magnetom MRI systems. The solution offers the potential to reduce costly re-scans resulting from inadequate image results -- issues that could cost hospitals and insurers millions annually.

Mr. Jones brings more than two decades of experience growing GE businesses, and especially GE Healthcare through corporate development, M&A, equity investing, and partnership activities. Under his leadership, GEHC grew from $2B to $18B in annual revenues. Prior to joining GE, Mike spent a decade as an investment banker, focused on M&A advisory and capital raising for global technology companies. Mike graduated from Princeton University with a bachelor's in economics, cum laude, in 1987.

"Movement during MRI procedures is incredibly disruptive and costly. As many as one in five MRI procedures fail due to patient movement, and can cause hospitals to repeat MRI scans, which might cost up to approximately $150,000 per year, per MRI system," said Jones. "I'm excited to participate in bringing KinetiCor's patented motion detection software to more hospitals and patients, and to expand its ecosystem of partners worldwide."

Mr. Donzelli added: "Our platform has the potential to bring a new level of clarity to medical imaging, and is ideally suited to work with all major MRI systems. Adding Mike to our advisory board will help us capitalize on our technical leadership and market opportunity. We are proud to add a proven industry veteran to our ranks and look forward to our future achievements together."

About KinetiCor:

KinetiCor, founded in 2009, is a medical system company dedicated to improving the quality of medical imaging via its patented prospective motion correction technology. The KinetiCor platform is currently FDA 510.

Media Contact:
press@ktcmarketingandpr.com


1FDA 510(k) certification references use in only Siemens Healthineers 1.5T Magnetom Amira and Sempra scanners

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2020 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.